Clinical Trial Update: TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating the combination of TACE, Axitinib, and Hydroxychloroquine for liver-dominant metastatic colorectal cancer has been termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Axitinib (Inlyta) (Axitinib)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Colorectal Neoplasms Malignant | Phase 1 | Status: TERMINATED